Advertisement

Archives of Gynecology and Obstetrics

, Volume 286, Issue 5, pp 1247–1253 | Cite as

Neuroendocrine tumor of the uterine cervix: a clinicopathologic study of 14 cases

  • Peng PengEmail author
  • Wu Ming
  • Yang Jiaxin
  • Shen Keng
Gynecologic Oncology

Abstract

Purpose

The study explored the clinicopathologic characteristics of the neuroendocrine tumor of uterine cervix (NTUC).

Methods

The general information and the clinical–pathological characteristics of 14 NTUC cases were reviewed.

Results

The median age of the cases was 41 years. Six cases (42.9 %) were FIGO stage Ib1, four cases (28.6 %) were Ib2, one case was IIa2 (7.1 %), one case (7.1 %) was IIb, one case (7.1 %) was IIIb and one case (7.1 %) was IVb. Radical hysterectomy and bilateral salpingo-oophorotomy plus pelvic lymphadenectomy were performed on seven cases: three cases had radical hysterectomy plus pelvic lymphadenectomy; one case had transabdominal hysterectomy; and one case had a residual cervical resection. Four cases had positive pelvic lymph nodes. Two cases (14.3 %) had the tumor infiltrated to the parametrium and five cases (35.7 %) to lymphovascular space. One case had positive margin of vagina. Nine cases (64.3 %) were administered post-surgery radiotherapy and all cases were given adjuvant chemotherapy. The median follow-up time was 10 months. The median disease-free survival was 6 months, and the median total survival time was 18 months. The median estimated survival time was 32.0 months (95 % CI 16.9–47.1 months).

Conclusions

NTUC is a very rare malignant tumor of female genital tract. Multi-center cooperation to gather more cases is the best method to explore the biological behavior and for the proper treatment of NTUC.

Keywords

Neuroendocrine Carcinoma Cervix Prognosis Treatment 

Notes

Conflict of interest

We declare that we have no conflict of interest.

References

  1. 1.
    Crowder S, Tuller E (2007) Small cell carcinoma of the female genital tract. Semin Oncol 34(1):57–63. doi: 10.1053/j.seminoncol.2006.10.028 PubMedCrossRefGoogle Scholar
  2. 2.
    Albores-Saavedra J, Gersell D, Gilks CB, Henson DE, Lindberg G, Santiago H, Scully RE, Silva E, Sobin LH, Tavassoli FJ, Travis WD, Woodruff JM (1997) Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 121(1):34–39PubMedGoogle Scholar
  3. 3.
    Albores- Saavedra J, Poucell S, Rodriguez- Martinez HA (1972) Primary carcinoid of the uterine cervix. Patologia 10:185–193Google Scholar
  4. 4.
    Wang KL, Yang YC, Wang TY, Chen JR, Chen TC, Chen HS, Su TH, Wang KG (2006) Neuroendocrine carcinoma of the uterine cervix: a clinicopathologic retrospective study of 31 cases with prognostic implications. J Chemother 18(2):209–216PubMedGoogle Scholar
  5. 5.
    Chen J, Macdonald OK, Gaffney DK (2008) Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol 111(6):1394–1402. doi: 10.1097/AOG.0b013e318173570b PubMedCrossRefGoogle Scholar
  6. 6.
    Tsunoda S, Jobo T, Arai M, Imai M, Kanai T, Tamura T, Watanabe J, Obokata A, Kuramoto H (2005) Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases. Int J Gynecol Cancer 15(2):295–300. doi: 10.1111/j.1525-1438.2005.15219.x PubMedCrossRefGoogle Scholar
  7. 7.
    Wang KL, Wang TY, Huang YC, Lai JC, Chang TC, Yen MS (2009) Human papillomavirus type and clinical manifestation in seven cases of large-cell neuroendocrine cervical carcinoma. J Formos Med Assoc 108(5):428–432. doi: 10.1016/S0929-6646(09)60088-7 PubMedCrossRefGoogle Scholar
  8. 8.
    Powell JL, McKinney CD (2008) Large cell neuroendocrine tumor of the cervix and human papillomavirus 16: a case report. J Low Genit Tract Dis 12(3):242–244. doi: 10.1097/LGT.0b013e3181641b4f PubMedCrossRefGoogle Scholar
  9. 9.
    Ishida GM, Kato N, Hayasaka T, Saito M, Kobayashi H, Katayama Y, Sasou S, Yaegashi N, Kurachi H, Motoyama T (2004) Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study. Int J Gynecol Pathol 23(4):366–372 [pii: 00004347-200410000-00009]PubMedCrossRefGoogle Scholar
  10. 10.
    Ng WK, Cheung LK, Li AS (2003) Thin-layer cytology findings of small cell carcinoma of the lower female genital tract. Review of three cases with molecular analysis. Acta Cytol 47:56–64PubMedCrossRefGoogle Scholar
  11. 11.
    Ciesla MC, Guidos BJ, Selvaggi SM (2001) Cytomorphology of small-cell (neuroendocrine) carcinoma on ThinPrep cytology as compared to conventional smears. Diagn Cytopathol 24:46–52PubMedCrossRefGoogle Scholar
  12. 12.
    Kim Y, Ha HJ, Kim JS et al (2002) Significance of cytologic smears in the diagnosis of small cell carcinoma of the uterine cervix. Acta Cytol 46:637–644PubMedCrossRefGoogle Scholar
  13. 13.
    Kataoka TR, Tsukamoto Y, Matsumura M, Miyake A, Kamiura S, Ishiguro S, Nishizawa Y (2008) Expression of p21Cip1/Waf1 and p27Kip1 in small cell neuroendocrine carcinoma of the uterine cervix. Int J Surg Pathol 16(1):11–15. doi: 10.1177/1066896907309574 PubMedCrossRefGoogle Scholar
  14. 14.
    Herrington CS, Graham D, Southern SA, Bramdev A, Chetty R (1999) Loss of retinoblastoma protein expression is frequent in small cell neuroendocrine carcinoma of the cervix and is unrelated to HPV type. Hum Pathol 30(8):906–910PubMedCrossRefGoogle Scholar
  15. 15.
    Wistuba II, Thomas B, Behrens C, Onuki N, Lindberg G, Albores-Saavedra J, Gazdar AF (1999) Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol 72(1):3–9. doi: 10.1006/gyno.1998.5248 PubMedCrossRefGoogle Scholar
  16. 16.
    Albores-Saavedra J, Latif S, Carrick KS et al (2005) CD56 reactivity in small cell carcinoma of the uterine cervix. Int J Gynecol Pathol 24:113–118PubMedCrossRefGoogle Scholar
  17. 17.
    Lee JM, Lee KB, Nam JH, Ryu SY, Bae DS, Park JT, Kim SC, Cha SD, Kim KR, Song SY, Kang SB (2008) Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol 19(2):321–326. doi: 10.1093/annonc/mdm465 PubMedCrossRefGoogle Scholar
  18. 18.
    Kasamatsu T, Sasajima Y, Onda T, Sawada M, Kato T, Tanikawa M (2007) Surgical treatment for neuroendocrine carcinoma of the uterine cervix. Int J Gynaecol Obstet 99(3):225–228. doi: 10.1016/j.ijgo.2007.06.051 PubMedCrossRefGoogle Scholar
  19. 19.
    Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ (2004) Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93(1):27–33. doi: 10.1016/j.ygyno.2003.12.027 PubMedCrossRefGoogle Scholar
  20. 20.
    Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ (2003) Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 97(3):568–574. doi: 10.1002/cncr.11086 PubMedCrossRefGoogle Scholar
  21. 21.
    Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH (1998) Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 83(4):712–718. doi: 10.1002/(SICI)1097-0142(19980815)83:4<712::AID-CNCR12>3.0.CO;2-V PubMedCrossRefGoogle Scholar
  22. 22.
    Yu A, Zhang P, Lou H (2002) Clinicophathologic characteristics and treatment of small cell carcinoma of uterine cervix. Zhonghua Zhong Liu Za Zhi 24(4):400–403PubMedGoogle Scholar
  23. 23.
    Boruta DM 2nd, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE (2001) Multimodality therapy in early stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 81(1):82–87. doi: 10.1006/gyno.2000.6118 PubMedCrossRefGoogle Scholar
  24. 24.
    Lee SS, Lee JL, Ryu MH (2007) Extrapulmonary small cell carcinoma: single center experience with 61 patients. Acta Oncol 46:846–851PubMedCrossRefGoogle Scholar
  25. 25.
    Tangjitgamol S, Manusirivithaya S, Choomchuay N, Leelahakorn S, Thawaramara T, Pataradool K, Suekwatana P (2007) Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix. J Obstet Gynaecol Res 33(2):218–224. doi: 10.1111/j.1447-0756.2007.00509.x PubMedCrossRefGoogle Scholar
  26. 26.
    Embry JR, Kelly MG, Post MD, Spillman MA (2011) Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy. Gynecol Oncol 120(3):444–448. doi: 10.1016/j.ygyno.2010.11.007 PubMedCrossRefGoogle Scholar
  27. 27.
    Hoskins PJ, Swenerton KD, Pike JA, Lim P, Aquino-Parsons C, Wong F, Lee N (2003) Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 21(18):3495–3501. doi: 10.1200/JCO.2003.01.501 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyPeking Union Medical College HospitalBeijingPeople’s Republic of China

Personalised recommendations